Literature DB >> 22378700

Programming and reprogramming neuronal subtypes in the central nervous system.

Caroline Rouaux1, Salman Bhai, Paola Arlotta.   

Abstract

Recent discoveries in nuclear reprogramming have challenged the dogma that the identity of terminally differentiated cells cannot be changed. The identification of molecular mechanisms that reprogram differentiated cells to a new identity carries profound implications for regenerative medicine across organ systems. The central nervous system (CNS) has historically been considered to be largely immutable. However, recent studies indicate that even the adult CNS is imparted with the potential to change under the appropriate stimuli. Here, we review current knowledge regarding the capability of distinct cells within the CNS to reprogram their identity and consider the role of developmental signals in directing these cell fate decisions. Finally, we discuss the progress and current challenges of using developmental signals to precisely direct the generation of individual neuronal subtypes in the postnatal CNS and in the dish.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22378700      PMCID: PMC4123849          DOI: 10.1002/dneu.22018

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  106 in total

1.  CHANGES IN THE NUCLEI OF DIFFERENTIATING GASTRULA CELLS, AS DEMONSTRATED BY NUCLEAR TRANSPLANTATION.

Authors:  T J King; R Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  1955-05-15       Impact factor: 11.205

2.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.

Authors:  Francesco Paolo Di Giorgio; Monica A Carrasco; Michelle C Siao; Tom Maniatis; Kevin Eggan
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

3.  Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex.

Authors:  Olga Britanova; Camino de Juan Romero; Amanda Cheung; Kenneth Y Kwan; Manuela Schwark; Andrea Gyorgy; Tanja Vogel; Sergey Akopov; Miso Mitkovski; Denes Agoston; Nenad Sestan; Zoltán Molnár; Victor Tarabykin
Journal:  Neuron       Date:  2008-02-07       Impact factor: 17.173

Review 4.  Molecular mechanisms of axon guidance in the developing corticospinal tract.

Authors:  A J Canty; M Murphy
Journal:  Prog Neurobiol       Date:  2008-02-15       Impact factor: 11.685

5.  Directed expression of Gata2, Mash1, and Foxa2 synergize to induce the serotonergic neuron phenotype during in vitro differentiation of embryonic stem cells.

Authors:  Christian M Nefzger; John M Haynes; Colin W Pouton
Journal:  Stem Cells       Date:  2011-06       Impact factor: 6.277

6.  Prospective isolation of cortical interneuron precursors from mouse embryonic stem cells.

Authors:  Asif Mirza Maroof; Keith Brown; Song-Hai Shi; Lorenz Studer; Stewart A Anderson
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

7.  Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.

Authors:  Bin Chen; Laura R Schaevitz; Susan K McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

Review 8.  Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.

Authors:  Maria C Marchetto; Kristen J Brennand; Leah F Boyer; Fred H Gage
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

9.  Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia.

Authors:  Benedikt Berninger; Marcos R Costa; Ursula Koch; Timm Schroeder; Bernd Sutor; Benedikt Grothe; Magdalena Götz
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  7 in total

1.  The transcription factor Fezf2 directs the differentiation of neural stem cells in the subventricular zone toward a cortical phenotype.

Authors:  Annalisa Zuccotti; Corentin Le Magueresse; Min Chen; Angela Neitz; Hannah Monyer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

Review 2.  Epigenetic setting and reprogramming for neural cell fate determination and differentiation.

Authors:  Takuya Imamura; Masahiro Uesaka; Kinichi Nakashima
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

Review 3.  Prospects for engineering neurons from local neocortical cell populations as cell-mediated therapy for neurological disorders.

Authors:  Stanley Bazarek; Daniel A Peterson
Journal:  J Comp Neurol       Date:  2014-05-13       Impact factor: 3.215

4.  FOXG1 sequentially orchestrates subtype specification of postmitotic cortical projection neurons.

Authors:  Junhua Liu; Mengjie Yang; Mingzhao Su; Bin Liu; Kaixing Zhou; Congli Sun; Ru Ba; Baocong Yu; Baoshen Zhang; Zhe Zhang; Wenxin Fan; Kun Wang; Min Zhong; Junhai Han; Chunjie Zhao
Journal:  Sci Adv       Date:  2022-05-25       Impact factor: 14.957

5.  Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo.

Authors:  Caroline Rouaux; Paola Arlotta
Journal:  Nat Cell Biol       Date:  2013-01-20       Impact factor: 28.824

Review 6.  Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasia.

Authors:  Gonçalo Regalo; Achim Leutz
Journal:  EMBO Mol Med       Date:  2013-07-04       Impact factor: 12.137

7.  Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons.

Authors:  Kangmu Ma; Xiaobei Deng; Xiaohuan Xia; Zhaohuan Fan; Xinrui Qi; Yongxiang Wang; Yuju Li; Yizhao Ma; Qiang Chen; Hui Peng; Jianqing Ding; Chunhong Li; Yunlong Huang; Changhai Tian; Jialin C Zheng
Journal:  Transl Neurodegener       Date:  2018-11-05       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.